Title
Leishmania donovani: Expression and characterization of Escherichia coli-expressed recombinant chitinase LdCHT1
Date Issued
01 January 2001
Access level
metadata only access
Resource Type
journal article
Author(s)
Razek-Desouky A.
Specht C.A.
Soong L.
University Boulevard
Publisher(s)
Elsevier
Abstract
Leishmania parasites produce chitinase activity (EC. 3.2.1.14) thought to be important in parasite-sandfly interactions and transmission of the parasite to the vertebrate host. Previous observations have suggested that parasite chitinases are involved in degradation of the sandfly peritrophic matrix and the chitinous layer of the cardiac valve cuticle. This chitinase activity is thought to produce an incompetent pharyngeal valve sphincter and a route of egress that allow Leishmania promastigotes to be regurgitated into the site of blood feeding. In the studies reported here, enzymatically active L. donovani chitinase LdCHT1 was expressed as a thioredoxin fusion protein in Escherichia coli strain AD494 (DE3). Recombinant LdCHT1 had a predominantly endochitinase activity, in contrast to previous reports of both exoand endochitinase activities in axenic culture supernatants of diverse Leishmania spp. promastigotes. The predominant endochitinase activity of recombinant LdCHT1 is consistent with the presumed function of the enzyme in disrupting chitinous structures in the sandfly digestive system to allow transmission. © 2001 Elsevier Science (USA).
Start page
220
End page
225
Volume
99
Issue
4
Language
English
OCDE Knowledge area
Parasitología
Scopus EID
2-s2.0-0035726650
PubMed ID
Source
Experimental Parasitology
ISSN of the container
00144894
Sponsor(s)
We thank Dr. Robert Tesh for providing the L. donovani strain MHOM/In/54 WR352 for use in this study. The support of the Egyptian Ministry of Higher Education and Scientific Research is gratefully acknowledged (A.R-D.). This work was funded in part by the Texas Higher Education Coordinating Board Advanced Research Program (J.M.V.) and NIH Grant GM-31318 (C.A.S.). J.M.V. is a Culpeper Medical Sciences Scholar supported by the Rockefeller Brothers Fund.
Sources of information: Directorio de Producción Científica Scopus